LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 19

Search options

  1. Article ; Online: Editorial: the role of vitamin D metabolites in the evaluation of bone health: are they physiologically relevant?

    Liu, Eva S / LeBoff, Meryl S

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

    2024  Volume 39, Issue 1, Page(s) 1–2

    MeSH term(s) Vitamin D ; Bone Density ; Ergocalciferols ; Bone and Bones
    Chemical Substances Vitamin D (1406-16-2) ; Ergocalciferols
    Language English
    Publishing date 2024-04-17
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 632783-7
    ISSN 1523-4681 ; 0884-0431
    ISSN (online) 1523-4681
    ISSN 0884-0431
    DOI 10.1093/jbmr/zjad012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Impaired 1,25-dihydroxyvitamin D3 action underlies enthesopathy development in the Hyp mouse model of X-linked hypophosphatemia.

    Rana, Rakshya / Baker, Jiana T / Sorsby, Melissa / Jagga, Supriya / Venkat, Shreya / Almardini, Shaza / Liu, Eva S

    JCI insight

    2023  Volume 8, Issue 17

    Abstract: X-linked hypophosphatemia (XLH) is characterized by high serum fibroblast growth factor 23 (FGF23) levels, resulting in impaired 1,25-dihydroxyvitamin D3 (1,25D) production. Adults with XLH develop a painful mineralization of the tendon-bone attachment ... ...

    Abstract X-linked hypophosphatemia (XLH) is characterized by high serum fibroblast growth factor 23 (FGF23) levels, resulting in impaired 1,25-dihydroxyvitamin D3 (1,25D) production. Adults with XLH develop a painful mineralization of the tendon-bone attachment site (enthesis), called enthesopathy. Treatment of mice with XLH (Hyp) with 1,25D or an anti-FGF23 Ab, both of which increase 1,25D signaling, prevents enthesopathy. Therefore, we undertook studies to determine a role for impaired 1,25D action in enthesopathy development. Entheses from mice lacking vitamin D 1α-hydroxylase (Cyp27b1) (C-/-) had a similar enthesopathy to Hyp mice, whereas deletion of Fgf23 in Hyp mice prevented enthesopathy, and deletion of both Cyp27b1 and Fgf23 in mice resulted in enthesopathy, demonstrating that the impaired 1,25D action due to high FGF23 levels underlies XLH enthesopathy development. Like Hyp mice, enthesopathy in C-/- mice was observed by P14 and was prevented, but not reversed, with 1,25D therapy. Deletion of the vitamin D receptor in scleraxis-expressing cells resulted in enthesopathy, indicating that 1,25D acted directly on enthesis cells to regulate enthesopathy development. These results show that 1,25D signaling was necessary for normal postnatal enthesis maturation and played a role in XLH enthesopathy development. Optimizing 1,25D replacement in pediatric patients with XLH is necessary to prevent enthesopathy.
    MeSH term(s) Mice ; Animals ; Familial Hypophosphatemic Rickets/genetics ; Calcitriol ; Enthesopathy ; 25-Hydroxyvitamin D3 1-alpha-Hydroxylase ; Fibroblast Growth Factors ; Vitamin D
    Chemical Substances Calcitriol (FXC9231JVH) ; 25-Hydroxyvitamin D3 1-alpha-Hydroxylase (EC 1.14.15.18) ; Fibroblast Growth Factors (62031-54-3) ; Vitamin D (1406-16-2)
    Language English
    Publishing date 2023-09-08
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ISSN 2379-3708
    ISSN (online) 2379-3708
    DOI 10.1172/jci.insight.163259
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Impaired Growth Plate Maturation in XLH Is due to Both Excess FGF23 and Decreased 1,25-Dihydroxyvitamin D Signaling.

    Yadav, Prem Swaroop / Kobelski, Margaret M / Martins, Janaina S / Tao, Tao / Liu, Eva S / Demay, Marie B

    Endocrinology

    2023  Volume 165, Issue 1

    Abstract: X-linked hypophosphatemia (XLH) is the most common form of hereditary hypophosphatemic rickets. The genetic basis for XLH is loss of function mutations in the phosphate-regulating endopeptidase X-linked (PHEX), which leads to increased circulating ... ...

    Abstract X-linked hypophosphatemia (XLH) is the most common form of hereditary hypophosphatemic rickets. The genetic basis for XLH is loss of function mutations in the phosphate-regulating endopeptidase X-linked (PHEX), which leads to increased circulating fibroblast growth factor 23 (FGF23). This increase in FGF23 impairs activation of vitamin D and attenuates renal phosphate reabsorption, leading to rickets. Previous studies have demonstrated that ablating FGF23 in the Hyp mouse model of XLH leads to hyperphosphatemia, high levels of 1,25-dihydroxyvitamin D, and is not associated with the development of rickets. Studies were undertaken to define a role for the increase in 1,25-dihydroxyvitamin D levels in the prevention of rickets in Hyp mice lacking FGF23. These mice were mated to mice lacking Cyp27b1, the enzyme responsible for activating vitamin D metabolites, to generate Hyp mice lacking both FGF23 and 1,25-dihydroxyvitamin D (FCH mice). Mice were fed a special diet to maintain normal mineral ion homeostasis. Despite normal mineral ions, Hyp mice lacking both FGF23 and Cyp27b1 developed rickets, characterized by an interrupted, expanded hypertrophic chondrocyte layer and impaired hypertrophic chondrocyte apoptosis. This phenotype was prevented when mice were treated with 1,25-dihydroxyvitamin D from day 2 until sacrifice on day 30. Interestingly, mice lacking FGF23 and Cyp27b1 without the PHEX mutation did not exhibit rickets. These findings define an essential PHEX-dependent, FGF23-independent role for 1,25-dihydroxyvitamin D in XLH and have important therapeutic implications for the treatment of this genetic disorder.
    MeSH term(s) Animals ; Mice ; 25-Hydroxyvitamin D3 1-alpha-Hydroxylase/genetics ; Familial Hypophosphatemic Rickets/metabolism ; Fibroblast Growth Factors/genetics ; Fibroblast Growth Factors/metabolism ; Growth Plate/metabolism ; Minerals/therapeutic use ; Phosphates ; Vitamin D/metabolism
    Chemical Substances 1,25-dihydroxyvitamin D (66772-14-3) ; 25-Hydroxyvitamin D3 1-alpha-Hydroxylase (EC 1.14.15.18) ; Fgf23 protein, mouse ; Fibroblast Growth Factors (62031-54-3) ; Minerals ; Phosphates ; Vitamin D (1406-16-2) ; Phex protein, mouse (EC 3.4.24.-)
    Language English
    Publishing date 2023-12-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 427856-2
    ISSN 1945-7170 ; 0013-7227
    ISSN (online) 1945-7170
    ISSN 0013-7227
    DOI 10.1210/endocr/bqad186
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Impaired 1,25 dihydroxyvitamin D3 action and hypophosphatemia underlie the altered lacuno-canalicular remodeling observed in the Hyp mouse model of XLH.

    Yuan, Ye / Jagga, Supriya / Martins, Janaina S / Rana, Rakshya / Pajevic, Paola Divieti / Liu, Eva S

    PloS one

    2021  Volume 16, Issue 5, Page(s) e0252348

    Abstract: Osteocytes remodel the perilacunar matrix and canaliculi. X-linked hypophosphatemia (XLH) is characterized by elevated serum levels of fibroblast growth factor 23 (FGF23), leading to decreased 1,25 dihydroxyvitamin D3 (1,25D) production and ... ...

    Abstract Osteocytes remodel the perilacunar matrix and canaliculi. X-linked hypophosphatemia (XLH) is characterized by elevated serum levels of fibroblast growth factor 23 (FGF23), leading to decreased 1,25 dihydroxyvitamin D3 (1,25D) production and hypophosphatemia. Bones from mice with XLH (Hyp) have enlarged osteocyte lacunae, enhanced osteocyte expression of genes of bone remodeling, and impaired canalicular structure. The altered lacuno-canalicular (LCN) phenotype is improved with 1,25D or anti-FGF23 antibody treatment, pointing to roles for 1,25D and/or phosphate in regulating this process. To address whether impaired 1,25D action results in LCN alterations, the LCN phenotype was characterized in mice lacking the vitamin D receptor (VDR) in osteocytes (VDRf/f;DMP1Cre+). Mice lacking the sodium phosphate transporter NPT2a (NPT2aKO) have hypophosphatemia and high serum 1,25D levels, therefore the LCN phenotype was characterized in these mice to determine if increased 1,25D compensates for hypophosphatemia in regulating LCN remodeling. Unlike Hyp mice, neither VDRf/f;DMP1Cre+ nor NPT2aKO mice have dramatic alterations in cortical microarchitecture, allowing for dissecting 1,25D and phosphate specific effects on LCN remodeling in tibial cortices. Histomorphometric analyses demonstrate that, like Hyp mice, tibiae and calvariae in VDRf/f;DMP1Cre+ and NPT2aKO mice have enlarged osteocyte lacunae (tibiae: 0.15±0.02μm2(VDRf/f;DMP1Cre-) vs 0.19±0.02μm2(VDRf/f;DMP1Cre+), 0.12±0.02μm2(WT) vs 0.18±0.0μm2(NPT2aKO), calvariae: 0.09±0.02μm2(VDRf/f;DMP1Cre-) vs 0.11±0.02μm2(VDRf/f;DMP1Cre+), 0.08±0.02μm2(WT) vs 0.13±0.02μm2(NPT2aKO), p<0.05 all comparisons) and increased immunoreactivity of bone resorption marker Cathepsin K (Ctsk). The osteocyte enriched RNA isolated from tibiae in VDRf/f;DMP1Cre+ and NPT2aKO mice have enhanced expression of matrix resorption genes that are classically expressed by osteoclasts (Ctsk, Acp5, Atp6v0d2, Nhedc2). Treatment of Ocy454 osteocytes with 1,25D or phosphate inhibits the expression of these genes. Like Hyp mice, VDRf/f;DMP1Cre+ and NPT2aKO mice have impaired canalicular organization in tibia and calvaria. These studies demonstrate that hypophosphatemia and osteocyte-specific 1,25D actions regulate LCN remodeling. Impaired 1,25D action and low phosphate levels contribute to the abnormal LCN phenotype observed in XLH.
    MeSH term(s) Animals ; Bone Remodeling ; Calcitriol/deficiency ; Cell Line ; Disease Models, Animal ; Familial Hypophosphatemic Rickets/metabolism ; Female ; Fibroblast Growth Factor-23 ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Osteocytes/metabolism ; Osteocytes/pathology ; Vitamin D Deficiency/metabolism
    Chemical Substances Fgf23 protein, mouse ; Fibroblast Growth Factor-23 (7Q7P4S7RRE) ; Calcitriol (FXC9231JVH)
    Language English
    Publishing date 2021-05-27
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0252348
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: 1,25-Dihydroxyvitamin D3 regulates furin-mediated FGF23 cleavage.

    Xie, Han / Bastepe, Isinsu / Zhou, Wen / Ay, Birol / Ceraj, Zara / Portales-Castillo, Ignacio A / Liu, Eva S / Burnett-Bowie, Sherri-Ann M / Jüppner, Harald / Rhee, Eugene P / Bastepe, Murat / Simic, Petra

    JCI insight

    2023  Volume 8, Issue 17

    Abstract: Intact fibroblast growth factor 23 (iFGF23) is a phosphaturic hormone that is cleaved by furin into N-terminal and C-terminal fragments. Several studies have implicated vitamin D in regulating furin in infections. Thus, we investigated the effect of 1,25- ...

    Abstract Intact fibroblast growth factor 23 (iFGF23) is a phosphaturic hormone that is cleaved by furin into N-terminal and C-terminal fragments. Several studies have implicated vitamin D in regulating furin in infections. Thus, we investigated the effect of 1,25-dihydroxyvitamin D3 [1,25(OH)2D] and the vitamin D receptor (VDR) on furin-mediated iFGF23 cleavage. Mice lacking VDR (Vdr-/-) had a 25-fold increase in iFGF23 cleavage, with increased furin levels and activity compared with wild-type (WT) littermates. Inhibition of furin activity blocked the increase in iFGF23 cleavage in Vdr-/- animals and in a Vdr-knockdown osteocyte OCY454 cell line. Chromatin immunoprecipitation revealed VDR binding to DNA upstream of the Furin gene, with more transcription in the absence of VDR. In WT mice, furin inhibition reduced iFGF23 cleavage, increased iFGF23, and reduced serum phosphate levels. Similarly, 1,25(OH)2D reduced furin activity, decreased iFGF23 cleavage, and increased total FGF23. In a post hoc analysis of a randomized clinical trial, we found that ergocalciferol treatment, which increased serum 1,25(OH)2D, significantly decreased serum furin activity and iFGF23 cleavage, compared with placebo. Thus, 1,25(OH)2D inhibits iFGF23 cleavage via VDR-mediated suppression of Furin expression, thereby providing a mechanism by which vitamin D can augment phosphaturic iFGF23 levels.
    MeSH term(s) Animals ; Mice ; Calcitriol/pharmacology ; Cell Line ; Chromatin Immunoprecipitation ; Furin ; Vitamin D
    Chemical Substances Calcitriol (FXC9231JVH) ; Furin (EC 3.4.21.75) ; Vitamin D (1406-16-2)
    Language English
    Publishing date 2023-09-08
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ISSN 2379-3708
    ISSN (online) 2379-3708
    DOI 10.1172/jci.insight.168957
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Molecular analysis of enthesopathy in a mouse model of hypophosphatemic rickets.

    Liu, Eva S / Martins, Janaina S / Zhang, Wanlin / Demay, Marie B

    Development (Cambridge, England)

    2018  Volume 145, Issue 15

    Abstract: The bone tendon attachment site known as the enthesis comprises a transitional zone between bone and tendon, and plays an important role in enabling movement at this site. X-linked hypophosphatemia (XLH) is characterized by impaired activation of vitamin ...

    Abstract The bone tendon attachment site known as the enthesis comprises a transitional zone between bone and tendon, and plays an important role in enabling movement at this site. X-linked hypophosphatemia (XLH) is characterized by impaired activation of vitamin D, elevated serum FGF23 levels and low serum phosphate levels, which impair bone mineralization. Paradoxically, an important complication of XLH is mineralization of the enthesis (enthesopathy). Studies were undertaken to identify the cellular and molecular pathways important for normal post-natal enthesis maturation and to examine their role during the development of enthesopathy in mice with XLH (Hyp). The Achilles tendon entheses of Hyp mice demonstrate an expansion of hypertrophic-appearing chondrogenic cells by P14. Post-natally, cells in wild-type and Hyp entheses similarly descend from scleraxis- and Sox9-expressing progenitors; however, Hyp entheses exhibit an expansion of Sox9-expressing cells, and enhanced BMP and IHH signaling. These results support a role for enhanced BMP and IHH signaling in the development of enthesopathy in XLH.
    MeSH term(s) Alkaline Phosphatase/metabolism ; Animals ; Basic Helix-Loop-Helix Transcription Factors/metabolism ; Bone Morphogenetic Proteins/metabolism ; Cell Proliferation/drug effects ; Chondrogenesis/drug effects ; Disease Models, Animal ; Enthesopathy/complications ; Enthesopathy/drug therapy ; Enthesopathy/genetics ; Enthesopathy/pathology ; Female ; Fibroblast Growth Factors/pharmacology ; Fibroblast Growth Factors/therapeutic use ; Hedgehog Proteins/metabolism ; Male ; Mice, Inbred C57BL ; Rickets, Hypophosphatemic/complications ; Rickets, Hypophosphatemic/drug therapy ; Rickets, Hypophosphatemic/genetics ; Rickets, Hypophosphatemic/pathology ; SOX9 Transcription Factor/metabolism ; Signal Transduction/drug effects ; Stem Cells/drug effects ; Stem Cells/metabolism ; Vitamin D/analogs & derivatives ; Vitamin D/pharmacology ; Vitamin D/therapeutic use
    Chemical Substances Basic Helix-Loop-Helix Transcription Factors ; Bone Morphogenetic Proteins ; Hedgehog Proteins ; SOX9 Transcription Factor ; Scx protein, mouse ; ihh protein, mouse ; Vitamin D (1406-16-2) ; Fibroblast Growth Factors (62031-54-3) ; 1,25-dihydroxyvitamin D (66772-14-3) ; fibroblast growth factor 23 (7Q7P4S7RRE) ; Alkaline Phosphatase (EC 3.1.3.1)
    Language English
    Publishing date 2018-08-10
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 90607-4
    ISSN 1477-9129 ; 0950-1991
    ISSN (online) 1477-9129
    ISSN 0950-1991
    DOI 10.1242/dev.163519
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: 1,25-Dihydroxyvitamin D Maintains Brush Border Membrane NaPi2a and Attenuates Phosphaturia in Hyp Mice.

    Martins, Janaina S / Liu, Eva S / Sneddon, W Bruce / Friedman, Peter A / Demay, Marie B

    Endocrinology

    2019  Volume 160, Issue 10, Page(s) 2204–2214

    Abstract: Phosphate homeostasis is critical for many cellular processes and is tightly regulated. The sodium-dependent phosphate cotransporter, NaPi2a, is the major regulator of urinary phosphate reabsorption in the renal proximal tubule. Its activity is dependent ...

    Abstract Phosphate homeostasis is critical for many cellular processes and is tightly regulated. The sodium-dependent phosphate cotransporter, NaPi2a, is the major regulator of urinary phosphate reabsorption in the renal proximal tubule. Its activity is dependent upon its brush border localization that is regulated by fibroblast growth factor 23 (FGF23) and PTH. High levels of FGF23, as are seen in the Hyp mouse model of human X-linked hypophosphatemia, lead to renal phosphate wasting. Long-term treatment of Hyp mice with 1,25-dihydroxyvitamin D (1,25D) or 1,25D analogues has been shown to improve renal phosphate wasting in the setting of increased FGF23 mRNA expression. Studies were undertaken to define the cellular and molecular basis for this apparent FGF23 resistance. 1,25D increased FGF23 protein levels in the cortical bone and circulation of Hyp mice but did not impair FGF23 cleavage. 1,25D attenuated urinary phosphate wasting as early as one hour postadministration, without suppressing FGF23 receptor/coreceptor expression. Although 1,25D treatment induced expression of early growth response 1, an early FGF23 responsive gene required for its phosphaturic effects, it paradoxically enhanced renal phosphate reabsorption and NaPi2a protein expression in renal brush border membranes (BBMs) within one hour. The Na-H+ exchange regulatory factor 1 (NHERF1) is a scaffolding protein thought to anchor NaPi2a to the BBM. Although 1,25D did not alter NHERF1 protein levels acutely, it enhanced NHERF1-NaPi2a interactions in Hyp mice. 1,25D also prevented the decrease in NHERF1/NaPi2a interactions in PTH-treated wild-type mice. Thus, these investigations identify a novel role for 1,25D in the hormonal regulation of renal phosphate handling.
    MeSH term(s) Animals ; Cell Line ; Epithelial Cells/drug effects ; Female ; Fibroblast Growth Factor-23 ; Fibroblast Growth Factors/metabolism ; Gene Expression Regulation/drug effects ; Hypophosphatemia/genetics ; Hypophosphatemia/metabolism ; Hypophosphatemia, Familial/prevention & control ; Kidney Tubules, Proximal/cytology ; MAP Kinase Signaling System ; Male ; Mice ; Protein Transport ; Receptors, Fibroblast Growth Factor ; Sodium-Phosphate Cotransporter Proteins, Type IIa/genetics ; Sodium-Phosphate Cotransporter Proteins, Type IIa/metabolism ; Vitamin D/analogs & derivatives ; Vitamin D/pharmacology
    Chemical Substances FGF23 protein, human ; Fgf23 protein, mouse ; Receptors, Fibroblast Growth Factor ; Sodium-Phosphate Cotransporter Proteins, Type IIa ; Vitamin D (1406-16-2) ; Fibroblast Growth Factors (62031-54-3) ; 1,25-dihydroxyvitamin D (66772-14-3) ; Fibroblast Growth Factor-23 (7Q7P4S7RRE)
    Language English
    Publishing date 2019-06-25
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 427856-2
    ISSN 1945-7170 ; 0013-7227
    ISSN (online) 1945-7170
    ISSN 0013-7227
    DOI 10.1210/en.2019-00186
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Highlights from the 24th workshop on vitamin D in Austin, September 2022.

    Meyer, Mark B / Bernal-Mizrachi, Carlos / Bikle, Daniel D / Biyani, Madhu / Campbell, Moray J / Chaudhari, Snehal N / Christakos, Sylvia / Ingles, Sue A / Knuth, Megan M / Lee, Seong Min / Lisse, Thomas S / Liu, Eva S / Piec, Isabelle / Plum, Lori A / Rao, Sudhaker D / Reynolds, Carmen J / Thacher, Tom D / White, John H / Cantorna, Margherita T

    The Journal of steroid biochemistry and molecular biology

    2023  Volume 228, Page(s) 106247

    Abstract: The 24th Workshop on Vitamin D was held September 7-9, 2022 in Austin, Texas and covered a wide diversity of research in the vitamin D field from across the globe. Here, we summarize the meeting, individual sessions, awards and presentations given. ...

    Abstract The 24th Workshop on Vitamin D was held September 7-9, 2022 in Austin, Texas and covered a wide diversity of research in the vitamin D field from across the globe. Here, we summarize the meeting, individual sessions, awards and presentations given.
    MeSH term(s) Humans ; Vitamin D ; Vitamin D Deficiency ; Vitamins
    Chemical Substances Vitamin D (1406-16-2) ; Vitamins
    Language English
    Publishing date 2023-01-10
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1049188-0
    ISSN 1879-1220 ; 0960-0760
    ISSN (online) 1879-1220
    ISSN 0960-0760
    DOI 10.1016/j.jsbmb.2023.106247
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Raf Kinases Are Essential for Phosphate Induction of ERK1/2 Phosphorylation in Hypertrophic Chondrocytes and Normal Endochondral Bone Development.

    Papaioannou, Garyfallia / Petit, Elizabeth T / Liu, Eva S / Baccarini, Manuela / Pritchard, Catrin / Demay, Marie B

    The Journal of biological chemistry

    2017  Volume 292, Issue 8, Page(s) 3164–3171

    Abstract: Hypophosphatemia causes rickets by impairing hypertrophic chondrocyte apoptosis. Phosphate induction of MEK1/2-ERK1/2 phosphorylation in hypertrophic chondrocytes is required for phosphate-mediated apoptosis and growth plate maturation. MEK1/2 can be ... ...

    Abstract Hypophosphatemia causes rickets by impairing hypertrophic chondrocyte apoptosis. Phosphate induction of MEK1/2-ERK1/2 phosphorylation in hypertrophic chondrocytes is required for phosphate-mediated apoptosis and growth plate maturation. MEK1/2 can be activated by numerous molecules including Raf isoforms. A- and B-Raf ablation in chondrocytes does not alter skeletal development, whereas ablation of C-Raf decreases hypertrophic chondrocyte apoptosis and impairs vascularization of the growth plate. However, ablation of C-Raf does not impair phosphate-induced ERK1/2 phosphorylation
    MeSH term(s) Animals ; Apoptosis ; Bone Development ; Cells, Cultured ; Chondrocytes/cytology ; Chondrocytes/metabolism ; Chondrocytes/pathology ; Chondrogenesis ; Growth Plate/growth & development ; Growth Plate/metabolism ; Mice, Inbred C57BL ; Mitogen-Activated Protein Kinase 1/metabolism ; Mitogen-Activated Protein Kinase 3/metabolism ; Phosphates/metabolism ; Phosphorylation ; Protein Isoforms/metabolism ; Proto-Oncogene Proteins A-raf/metabolism ; Proto-Oncogene Proteins B-raf/metabolism ; Proto-Oncogene Proteins c-raf/metabolism ; raf Kinases/metabolism
    Chemical Substances Phosphates ; Protein Isoforms ; Braf protein, mouse (EC 2.7.11.1) ; Proto-Oncogene Proteins A-raf (EC 2.7.11.1) ; Proto-Oncogene Proteins B-raf (EC 2.7.11.1) ; Proto-Oncogene Proteins c-raf (EC 2.7.11.1) ; raf Kinases (EC 2.7.11.1) ; Mitogen-Activated Protein Kinase 1 (EC 2.7.11.24) ; Mitogen-Activated Protein Kinase 3 (EC 2.7.11.24)
    Language English
    Publishing date 2017-01-10
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2997-x
    ISSN 1083-351X ; 0021-9258
    ISSN (online) 1083-351X
    ISSN 0021-9258
    DOI 10.1074/jbc.M116.763342
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Increased Circulating FGF23 Does Not Lead to Cardiac Hypertrophy in the Male Hyp Mouse Model of XLH.

    Liu, Eva S / Thoonen, Robrecht / Petit, Elizabeth / Yu, Binglan / Buys, Emmanuel S / Scherrer-Crosbie, Marielle / Demay, Marie B

    Endocrinology

    2018  Volume 159, Issue 5, Page(s) 2165–2172

    Abstract: Serum levels of fibroblast growth factor 23 (FGF23) markedly increase with renal impairment, with FGF23 levels correlating with the presence of left ventricular hypertrophy (LVH) and mortality in patients with chronic kidney disease (CKD). FGF23 ... ...

    Abstract Serum levels of fibroblast growth factor 23 (FGF23) markedly increase with renal impairment, with FGF23 levels correlating with the presence of left ventricular hypertrophy (LVH) and mortality in patients with chronic kidney disease (CKD). FGF23 activates calcineurin/nuclear factor of activated T cell (NFAT) signaling and induces hypertrophy in murine cardiomyocytes. X-linked hypophosphatemia (XLH) is characterized by high circulating levels of FGF23 but, in contrast to CKD, is associated with hypophosphatemia. The cardiac effects of high circulating levels of FGF23 in XLH are not well defined. Thus, studies were undertaken to define the cardiac phenotype in the mouse model of XLH (Hyp mice). Echocardiographic and histological analyses demonstrated that Hyp left ventricles (LVs) are smaller than those of wild-type mice. Messenger RNA expression of cardiac hypertrophy markers was not altered in the LV or right ventricle of Hyp mice. However, the Hyp LVs had increased expression of the NFAT target genes NFATc1 and RCAN1. To determine whether phosphate alone can induce markers of hypertrophy, differentiated C2C12 myocytes were treated with phosphate. Phosphate treatment increased expression of cardiac hypertrophy markers, supporting a primary role for phosphate in inducing LVH. Although previous studies showed that increased circulating FGF23 and phosphate levels are associated with LVH, our results demonstrated that in XLH, high circulating levels of FGF23 in the setting of hypophosphatemia do not induce cardiac hypertrophy.
    MeSH term(s) Animals ; Cardiomegaly/genetics ; Cardiomegaly/metabolism ; Disease Models, Animal ; Echocardiography ; Familial Hypophosphatemic Rickets/metabolism ; Fibroblast Growth Factors/metabolism ; Gene Expression ; Heart Ventricles/metabolism ; Heart Ventricles/pathology ; Hypertrophy, Left Ventricular/genetics ; Hypertrophy, Left Ventricular/metabolism ; Intracellular Signaling Peptides and Proteins/genetics ; Male ; Mice ; Muscle Proteins/genetics ; Myocardium/metabolism ; Myocardium/pathology ; NFATC Transcription Factors/genetics ; Organ Size ; RNA, Messenger/metabolism
    Chemical Substances DSCR1 protein, mouse ; Intracellular Signaling Peptides and Proteins ; Muscle Proteins ; NFATC Transcription Factors ; Nfatc1 protein, mouse ; RNA, Messenger ; Fibroblast Growth Factors (62031-54-3) ; fibroblast growth factor 23 (7Q7P4S7RRE)
    Language English
    Publishing date 2018-04-07
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 427856-2
    ISSN 1945-7170 ; 0013-7227
    ISSN (online) 1945-7170
    ISSN 0013-7227
    DOI 10.1210/en.2018-00174
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top